Niacin prediabetes supplement science abstracts related to diabetes and pre-diabetes metabolic syndrome health.
Go to PubMed and copy the title in the search field.
Lipid control in patients with diabetes mellitus.
Safety review of combination drugs for hyperlipidemia.
Extended-release niacin/laropiprant lipid-altering consistency across patient subgroups.
The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: Baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH) trial.
The Effect of Gemfibrozil, Niacin and Cholestyramine Combination Therapy on Metabolic Syndrome in the Armed Forces Regression Study.
Combination lipid therapy in type 2 diabetes mellitus.
Pleiotropic Effects of Nicotinic Acid: Beyond High Density Lipoprotein Cholesterol Elevation.
Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus.
Recent advances in preventing cardiovascular disorders by managing lipid levels.
Treatment of dyslipidemia in patients with type 2 diabetes.
Adjunctive lipid lowering therapy in the era of surrogate endpoints.
Low high-density lipoprotein cholesterol: current status and future strategies for management.
Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression.